• Alloderm Home
• Assigned Judges & Staff
• Calendar
• Case List
• Counsel Lists
• Forms
• Orders and Decisions
• Middlesex Home

AlloDerm

AlloDerm Regenerative Tissue Matrix ("AlloDerm") is a banked human tissue graft product developed, manufactured and marketed by the New Jersey firm LifeCell. It is a human cell and tissue-based product and thus is not classified by the FDA as a medical device, biologic product or drug. It is used to remodel into a range of functional tissues in the human body that provide structural support. This litigation involves actions seeking damages and/or other relief arising allegedly from the use of AlloDerm.

• Notice - Centralized Management of AlloDerm Litigation Designation and Assignment of AlloDerm Litigation (Includes the Supreme Court Order and Judge Mayer's Case Management Order 1 of AlloDerm Litigation)
• Notice - Mass Torts - Application for Mass Tort Designation of Litigation Involving AlloDerm Regenerative Tissue Matrix - Comments Sought (Posted: May 27, 2011)

Privacy Policy | Contact Us | © New Jersey Judiciary